SCHEMBL23192021

SCHEMBL23192021

Cc1ccc(S(=O)(=O)OC2CCCCCCCCCCCCC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.61
ALDH1A1 P00352 5/20 0.51
CYP3A4 P08684 2/20 0.51
TSHR P16473 1/20 0.51
CYP1A2 P05177 1/20 0.51
ENPP3 O14638 2/20 0.47
ENPP1 P22413 2/20 0.47
ENPP2 Q13822 2/20 0.47
POLB P06746 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 2/20 0.44
TP53 P04637 2/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
ACHE P22303 1/20 0.44
GAA P10253 2/20 0.43
KCNH2 Q12809 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL361129 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL8367865 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL8370244 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL11107669 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL22621292 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL24250706 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL9060935 1.00 CYP2D6 (0.61) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL777214 0.98 CYP2D6 (0.63) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
Methyl Alcohol SCHEMBL1553775 0.97 CYP2D6 (0.62) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL6198029 0.95 CYP2D6 (0.63) CYP2D6ALDH1A1CYP3A4TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11203612-B2 Methods of generating nanoarrays and microarrays NAUTILUS BIOTECHNOLOGY, INC. (US) 2021-12-21 US disclosed
US-20210390705-A1 METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES NAUTILUS SUBSIDIARY, INC. 2021-12-16 US disclosed
WO-2021252800-A1 METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES NAUTILUS BIOTECHNOLOGY, INC. (US) 2021-12-16 WO disclosed
US-20210101930-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAUTILUS BIOTECHNOLOGY, INC. 2021-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210101930-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAPA, SSBP1, NASP CYP2D6 4865/4885ALDH1A1 3935/4885CYP3A4 4873/4885
US-11203612-B2 Methods of generating nanoarrays and microarrays NAPA, SSBP1, NASP CYP2D6 4865/4885ALDH1A1 3935/4885CYP3A4 4873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.